Rx for Biotech

Reprogramming Immunity: How CCR5 Blockade Could Redefine Cancer Therapy


Listen Later

In this podcast episode, Dr. Jay Lalezari, CEO of CytoDyn Therapeutics, discusses the company's progress in developing a novel immunotherapy that targets the CCR5 receptor, one of the master immune cell regulators. Jay reviews some of the early clinical data with leronlimab, a first-in-class investigational monocolonal antibody that targets the CCR5 receptor and is being studied in metasatic triple-negative breast cancer and colorectal cancer.
...more
View all episodesView all episodes
Download on the App Store

Rx for BiotechBy Podcast Host Chris Leidli

  • 5
  • 5
  • 5
  • 5
  • 5

5

3 ratings


More shows like Rx for Biotech

View all
The Readout Loud by STAT

The Readout Loud

339 Listeners

Biotech 2050 Podcast by Biotech 2050

Biotech 2050 Podcast

60 Listeners

All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

All-In with Chamath, Jason, Sacks & Friedberg

10,189 Listeners

Business Of Biotech by Ben Comer

Business Of Biotech

85 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

34 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Biotech Hangout

21 Listeners

Cell & Gene: The Podcast by Erin Harris

Cell & Gene: The Podcast

38 Listeners

The Biotech Startups Podcast by Excedr

The Biotech Startups Podcast

24 Listeners

The BioCentury Show by BioCentury

The BioCentury Show

13 Listeners